Phase 1 Trial of Panobinostat + Ruxolitnib for Relapsed/Refactory Diffused Large B Cell Lymphoma (DLBCL)
Research Grant
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Lymphoma Research Foundation of America
Start Date
March 1, 2016
End Date
August 31, 2019
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Lymphoma Research Foundation of America
Start Date
March 1, 2016
End Date
August 31, 2019